MedTrace Logo

Profiling Spike Protein Antibody Response Post COVID-19 Booster

NCT05476822 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-03-24

No results posted yet for this study

Summary

A descriptive study that will quantify the mean IgG antibodies remaining in vaccinated healthy participants after their COVID booster.

Conditions

  • COVID-19 Booster
  • Spike Protein IgG Antibody

Interventions

DIAGNOSTIC_TEST

Obtain antibody titers

Obtain blood samples for antibody titers at the time of enrollment, at three months, six months and nine months post vaccine booster (+/- ten days).

Sponsors & Collaborators

  • David Grant U.S. Air Force Medical Center

    lead FED

Principal Investigators

  • Nolan R Hudson, MS · David Grant Medical Center, Travis AFB, CA

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-31
Primary Completion
2023-06-30
Completion
2023-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05476822 on ClinicalTrials.gov